LLRAPC Newsletter – April/May 2023(234 KB) - LMSG/LLR APC newsletters
Date added: 31st May 2023
| Drug Name | Classification | Clinical Indication | Comments |
|---|---|---|---|
| BIMATOPROST / TIMOLOL eye drops (UPDATED) | Green | Glaucoma |
If a combination product is considered appropriate. If a preservative free formulation is required, please prescribe the 3ml preservative free multi-dose containers as a first choice. Preservative free multi-dose containers are unsuitable for patients with a history of contact hypersensitivity to silver. Please use ‘unpreserved unit doses’ in their place. |
| BIMATOPROST / TIMOLOL preservative free eye drops (Ganfort UD®) | Green | Glaucoma | |
| BIMATOPROST preservative free eye drops (UPDATED) | Green | Glaucoma |
If a preservative free formulation is required, please prescribe the 3ml preservative free multi-dose containers as a first choice. Preservative free multi-dose containers are unsuitable for patients with a history of contact hypersensitivity to silver. Please use ‘unpreserved unit doses’ in their place. |
| DORZOLAMIDE / TIMOLOL eye drops (UPDATED) | Green | Glaucoma |
Prescribe generically. If a preservative free formulation is required, please prescribe the 5ml preservative free multi-dose containers as a first choice. Preservative free multi-dose containers are unsuitable for patients with a history of contact hypersensitivity to silver. Please use ‘unpreserved unit doses’ in their place. |
| DORZOLAMIDE eye drops (UPDATED) | Green | Glaucoma |
Prescribe generically. If a preservative free formulation is required, please prescribe the 5ml preservative free multi-dose containers as a first choice. Preservative free multi-dose containers are unsuitable for patients with a history of contact hypersensitivity to silver. Please use ‘unpreserved unit doses’ in their place. |
Other Updates on this Website
Recent documents from LLR APC and TAS
LLR APC Meeting Minutes April 2023(245 KB) - LMSG/LLR APC minutes
Date added: 4th May 2023
Infant Formula Prescribing Guidance(2 MB) - Guidelines
Version 2.4 uploaded May 2023
Date added: 14th Nov 2017
About the Leicester, Leicestershire and Rutland Area Prescribing Committee
In common with other local health communities, the Leicester, Leicestershire and Rutland Area Prescribing Committee (LLR APC) acknowledges the benefits of having a Leicestershire Health Community-wide strategy for the prescribing of specialist medicines and the managed entry of new drugs and related technologies.
Leicestershire Health Community comprises the Leicester, Leicestershire and Rutland Integrated Care Board, University Hospitals of Leicester (UHL) NHS Trust and Leicestershire Partnership NHS Trust (LPT), amongst which there is a total consensus on the need for this strategy, and the LLR APC has been in place since 2005. Learn more